house · trading 2018-06-28 → 2022-11-17
*Purchases reported over roughly the last three years, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings state a range, never a share count, so this tracks the stock rather than the position. It is not a dollar figure and it is not what this member made.
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2022-11-17 | GS | BUY | $15K–$50K | $379.78 | $893.28 2026-10-26 | +135.2% |
| 2018-06-28 | GSK | SELL | $1K–$15K | $39.57 | $51.10 2026-10-26 | -29.1% exit |
Buys are marked to the latest close and treated as still open. A sell tagged rt closes an earlier disclosed buy in the same name. exit reads from the seller's side: how the stock moved after they were out.
| Member | Shared tickers |
|---|---|
| Thomas H Tuberville | 2 · GSK, GS |
| Thomas R Carper | 2 · GSK, GS |
| John Boozman | 2 · GSK, GS |
| David P. Roe | 2 · GSK, GS |
| Mike Kelly | 2 · GSK, GS |
| Pete Sessions | 2 · GSK, GS |
| Katherine M. Clark | 2 · GSK, GS |
| Marjorie Taylor Mrs Greene | 2 · GSK, GS |
| Zoe Lofgren | 2 · GSK, GS |
| David Kustoff | 2 · GSK, GS |
| Rohit Khanna | 1 · GSK |
| Michael T. McCaul | 1 · GS |